| P50 | author | Owen M. Wolkowitz | Q59678011 |
| P2093 | author name string | J Zhang | |
| | J Lin | |
| | L Clarke | |
| | J R Seibold | |
| | H Weingartner | |
| | M G Murphy | |
| | K Grasing | |
| | K Putnam | |
| | D Freedholm | |
| | M Swigar | |
| P2860 | cites work | The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat | Q28278422 |
| | Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity | Q28334293 |
| | Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 |
| | PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes | Q33792380 |
| | Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder | Q34205234 |
| | CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat | Q34466681 |
| | Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. | Q35815910 |
| | Functional role of brain CCK receptors | Q37278765 |
| | Evidence for an involvement of the brain cholecystokinin B receptor in anxiety | Q37395948 |
| | The role of CCK caerulein, and CCK antagonists in nociception | Q38759937 |
| | Release of cholecystokinin in the central nervous system | Q40918018 |
| | The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder | Q41030900 |
| | The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans | Q43786284 |
| | Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. | Q45977303 |
| | Benzodiazepines antagonize cholecystokinin-induced activation of rat hippocampal neurones | Q46452290 |
| | Brain CCK receptors are structurally distinct from pancreas CCK receptors | Q48611898 |
| | Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. | Q51176483 |
| | LAGRAN program for area and moments in pharmacokinetic analysis. | Q51659721 |
| | Estimation of variance for harmonic mean half-lives. | Q52676346 |
| | An analysis of variance test for normality (complete samples) | Q57253423 |
| P433 | issue | 4 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| | cholecystokinin | Q60315441 |
| P304 | page(s) | 292-300 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | The Journal of Clinical Pharmacology | Q7743562 |
| P1476 | title | Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist. | |
| P478 | volume | 36 | |